Kinfo
AF

Aimei Health Technology Co., Ltd.

AFJKRNASDAQ·US · USD
$0.11
+0.00 (+2.70%)
Prices as of July 10, 2026 · market closed

Price

Key statistics

Valuation
Market cap0.00 USD
Enterprise value0.00 USD
Trailing P/E0.00
Forward P/E0.00
PEG ratio0.00
Price / sales0.00
Price / book0.00
Profitability
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on assets-1.08%
Return on equity0.00%
Income (TTM)
Revenue0.00 USD
Gross profit0.00 USD
EBITDA0.00 USD
Net income920.55K USD
Diluted EPS$0.00
Rev. growth (YoY)0.00%
Balance sheet
Total cash18.52K USD
Total debt2.09M USD
Debt / equity0.00
Current ratio0.01
Book value / share-$1.32
Cash flow (TTM)
Operating cash flow-415.70K USD
Levered free cash flow192.79K USD
Shares & price
Shares outstanding0.00
Float1.44M
Held by institutions0.00%
Beta0.55
50-day MA$0.00
200-day MA$0.00
52-week high$0.49
52-week low$0.07
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2025-11-043.163.01−4.75%
About Aimei Health Technology Co., Ltd.

Aimei Health Technology Co., Ltd. is a blank check company incorporated in 2023 and headquartered in New York. As a special purpose acquisition company, it was established to identify and execute a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more operating businesses. The company operates within the financial sector as a financial conglomerate, serving as a vehicle for investors seeking exposure to potential merger and acquisition opportunities. Aimei Health Technology Co., Ltd. trades on the Nasdaq under the symbol AFJKR, with rights issued that expire in November 2028. Through its structure, the company provides a mechanism for business consolidation and capital deployment in pursuit of strategic acquisitions and corporate restructuring initiatives.

CEO
Mr. Junheng Xie
Headquarters
New York, NY, United States

Frequently asked questions about Aimei Health Technology Co., Ltd.